Search

everythinglearnresearchcommunity

for

Search:↓

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Better hair loss models needed for research.

Ganoderma lucidum, a type of mushroom, may help treat enlarged prostate by blocking testosterone conversion.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Dosing time affects finasteride's effectiveness and safety in rats.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.